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Nuclear Hormone Receptor NHR-49
Controls Fat Consumption and Fatty Acid
Composition in C. elegans
Marc R. Van Gilst, Haralambos Hadjivassiliou, Amber Jolly, Keith R. Yamamoto*
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, United States of America
Mammalian nuclear hormone receptors (NHRs), such as liver X receptor, farnesoid X receptor, and peroxisome
proliferator-activated receptors (PPARs), precisely control energy metabolism. Consequently, these receptors are
important targets for the treatment of metabolic diseases, including diabetes and obesity. A thorough understanding
of NHR fat regulatory networks has been limited, however, by a lack of genetically tractable experimental systems.
Here we show that deletion of the Caenorhabditis elegans NHR gene nhr-49 yielded worms with elevated fat content
and shortened life span. Employing a quantitative RT-PCR screen, we found that nhr-49 influenced the expression of 13
genes involved in energy metabolism. Indeed, nhr-49 served as a key regulator of fat usage, modulating pathways that
control the consumption of fat and maintain a normal balance of fatty acid saturation. We found that the two
phenotypes of the nhr-49 knockout were linked to distinct pathways and were separable: The high-fat phenotype was
due to reduced expression of enzymes in fatty acid b-oxidation, and the shortened adult life span resulted from
impaired expression of a stearoyl-CoA desaturase. Despite its sequence relationship with the mammalian hepatocyte
nuclear factor 4 receptor, the biological activities of nhr-49 were most similar to those of the mammalian PPARs,
implying an evolutionarily conserved role for NHRs in modulating fat consumption and composition. Our findings in C.
elegans provide novel insights into how NHR regulatory networks are coordinated to govern fat metabolism.
Citation: Van Gilst MR, Hadjivassiliou H, Jolly A, Yamamoto KR (2005) Nuclear hormone receptor NHR-49 controls fat consumption and fatty acid composition in C. elegans.
PLoS Biol 3(2): e53.
Introduction
Due to their ability to interact with fatty acids and other
lipids, nuclear hormone receptors (NHRs), including perox-
isome proliferator-activated receptors (PPARs), liver X
receptor, and farnesoid X receptor, are important regulators
of mammalian fat metabolism; accordingly, these small-
molecule-gated transcription factors have been favored
targets for therapies designed to combat diabetes, obesity,
and atherosclerosis [1,2,3]. Although the molecular mecha-
nisms employed by NHRs have been intensively probed, their
pleiotropic effects on overall animal physiology are only
partially understood. Thus, developing a broader range of
experimental systems would be useful for characterizing the
fat regulatory networks integrated by NHRs and for revealing
the breadth of their physiological influence.
The study of invertebrates, such as Caenorhabditis elegans, has
facilitated the elucidation and interpretation of biological
networks, particularly in the context of the whole animal.
However, despite the fact that C. elegans contains 284 NHR
genes, compared to only 48 in mammals, there is a notable
absence of worm NHRs orthologous to mammalian receptors
involved in fat metabolism [4,5]. In fact, it has been suggested
that fat-regulating NHRs, along with several other NHR types,
were lost from the C. elegans and Drosophila lineages as these
organisms simplified their body plans [6]. Conceivably, then,
the biological activities associated with these NHRs may also
have vanished. Therefore, it is still not clear if worm receptors
mediate control over fat metabolism comparable to that of
mammalian NHRs.
Whether or not C. elegans employs NHRs to regulate fat
metabolism, the evolution of the C. elegans NHR family is
intrinsically interesting. Only 15 of the 284 worm NHRs are
members of the broadly conserved subfamilies found in
mammals and other metazoans [4,5]. The biological activities
ofmost of these ‘‘conserved’’NHRs have been broadly defined,
revealing roles in development, molting, dauer formation, and
sex determination [7,8]. The remaining 269 ‘‘divergent’’ NHRs
have thus far been found only in nematodes and are predicted
to have originated from repeated duplication of an ancestral
gene that also gave rise to the hepatocyte nuclear factor 4
(HNF4) family of receptors [6]. Although mammalian HNF4
receptors have been implicated in liver development and
glucose homeostasis [9], virtually nothing is known about the
functions of these 269 C. elegans ‘‘nematode-specific’’ HNF4-
like receptors. It will be interesting to determine if these
divergent NHRs have adopted novel regulatory functions or
whether they carry out physiological tasks similar to those of
other metazoan NHRs.
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Elucidating the physiological responsibilities of even one of
the worm HNF4-like receptors will likely advance our
understanding of NHR-regulated gene networks and provide
insight into the evolution and diversification of the NHR
family in nematodes. To this end, we have been systematically
investigating the function of HNF4-like receptors in C. elegans.
In this study, we present a physiological characterization of
nhr-49 (K10C3.6), one of the C. elegans receptor genes most
closely related to the mammalian HNF4. Our findings reveal a
surprising role for this HNF4-like receptor in the regulation
of fat storage and metabolism.
Results
nhr-49 Is Necessary for Normal Life Span
In an RNA interference (RNAi) screen designed to identify
the role of C. elegans HNF4-like receptors in worm develop-
ment and longevity, we found that interference of nhr-49
resulted in dramatically reduced life span (Figure 1A). For
further characterization, we obtained a C. elegans strain, nhr-
49(nr2041), which harbors a deletion in the nhr-49 gene
encompassing part of the DNA binding domain and more
than half of the ligand binding domain (LBD); this deletion
likely results in complete loss of function [10]. At 23 8C, nhr-
49(nr2041) worms lived only 6–8 d as adults, significantly
shorter than the 15 to 18-d life span of N2 wild-type (WT)
animals (Figure 1A). Although nhr-49 deletion did not
noticeably affect development or fertility, nhr-49(nr2041)
worms experienced rapid decline in function beginning
around day 3 of adulthood, when vacuoles appeared in the
intestine and gonad (Figure 1B). By days 4 and 5, nhr-
49(nr2041) animals were significantly smaller than WT,
vacuoles were ubiquitous, and there was widespread gonadal
necrosis. By days 5–7, the gonad had completely deteriorated,
and the worms died shortly thereafter. Thus, nhr-49 function
is not required for development or fertility, but is clearly
essential for normal longevity. Even though the increased
vacuole formation was consistent with reported aging
characteristics [11], we have not determined whether the
shortened life span of nhr-49(nr2041) reflects accelerated
aging or an unrelated pathology.
nhr-49(nr2041) Animals Display Abnormally High Fat
Content
nhr-49 was recently identified in a C. elegans genomewide
RNAi screen as one of 112 genes that, when knocked down by
RNAi, resulted in abnormally high Nile Red fat staining [12].
To determine whether deletion of nhr-49 also yielded a high-
fat phenotype, we used a similar Nile Red assay to visualize fat
content in nhr-49(nr2041). Indeed, we found that nhr-
49(nr2041) animals stained more brightly with Nile Red than
did WT worms (Figure 1C). The difference in fat content
between WT and nhr-49(nr2041) animals was most pro-
nounced in the L3 and L4 stages of larval development; by
Figure 1. nhr-49(nr2041) Animals Have Reduced Life Span and Higher Fat Content
(A) Adult life span of WT (black squares, solid line), nhr-49(nr2041) (black circles, dotted line), and nhr-49 RNAi animals (black diamonds, dashed
line).
(B) Nomarksi images of nhr-49(nr2041) at days 3, 5, and 7 of adulthood. The arrow in the day 3 image points to a gonadal vacuole that is typical of
day 3 worms; the arrow in the day 5 image shows the continued deterioration of oocytes in the gonad, and the arrow in the day 7 image points to
the clearing that results from complete gonadal necrosis and collapse.
(C) Nile Red intestinal fat staining of WT and nhr-49(nr2041). Each image displays two representative worms from a population of L4 animals.
DOI: 10.1371/journal.pbio.0030053.g001
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Figure 2. nhr-49 Deletion Affects the Expression of 13 Energy Metabolism Genes
Putative C. elegans fatty acid, glucose, and glyoxylate metabolism pathways are shown here; each box represents a gene predicted by sequence
homology to code for the enzyme indicated in the figure. The fatty acid desaturation elongation pathway is adapted from previously published
studies [14,17]. Mitochondrial localization of b-oxidation enzymes was predicted by TargetP and PSORT (see Materials and Methods);
peroxisomal b-oxidation enzymes all contain a carboxy-terminal peroxisomal localization signal. QRT-PCR was used to measure the expression
of these 89 genes in WT and nhr-49(nr2041). Genes expressed at lower levels in nhr-49(nr2041) are shown in red (.32-fold lower); orange (8- to 32-
fold lower); or yellow (2- to 8-fold lower); and genes expressed at higher levels are shown in light green (2- to 8-fold higher) or dark green (.8-
fold higher). Online QRT-PCR data for this analysis are available in Table S1.
DOI: 10.1371/journal.pbio.0030053.g002
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day 2 of adulthood there was only a slight change in Nile Red
staining, suggesting that the effects of nhr-49 on visible fat
content may vary during development (data not shown).
nhr-49 Regulates Genes Involved in Energy Metabolism
The high-fat phenotype of the nhr-49(nr2041) mutant led us
to suspect that nhr-49 might regulate genes involved in energy
metabolism. To test this hypothesis, we identified from a
survey of the C. elegans genome 65 genes predicted to
participate in fatty acid synthesis, b-oxidation, desaturation,
elongation, and binding/transport, in addition to 16 genes
expected to function in glycolysis, gluconeogenesis, and
glucose transport, and eight genes involved in the glyoxylate
pathway (Figure 2). We then employed quantitative RT-PCR
(QRT-PCR) to measure the expression of all 89 of these genes
in WT and nhr-49(nr2041) mutant worms. For the purpose of
our survey, gene expression was measured in all four larval
stages (for a complete dataset, see Table S1).
Our screen revealed that deletion of nhr-49 significantly
altered the expression of 13 genes, including six genes
predicted to be involved in fatty acid b-oxidation, three
genes involved in fatty acid desaturation, two genes involved
in fatty acid binding/transport, and two genes involved in the
glyoxylate pathway (Figure 2). Similar changes in gene
expression were observed when nhr-49 was knocked down in
WT animals using RNAi (data not shown).
Overall, nhr-49 deletion displayed the most dramatic effects
on two metabolic pathways, mitochondrial b-oxidation and
fatty acid desaturation, as the expression of multiple genes in
each of these pathways was significantly compromised by loss
of nhr-49 function (Figure 2). In contrast, nhr-49 deletion had
smaller and mixed consequences for genes that participate in
peroxisomal b-oxidation and lipid binding/transport. nhr-49
knockout also marginally reduced expression of two enzymes
involved in the glyoxylate pathway, a pathway that facilitates
the conversion of fatty acid b-oxidation products to glucose
(Figure 2). nhr-49 deletion did not, however, significantly
affect the expression of any genes predicted to be involved in
Figure 3. Regulation of b-Oxidation Gene Expression by nhr-49
(A) QRT-PCR measurement of acs-2, F09F9.3, and ech-1 expression in WT (gray bars) and nhr-49(nr2041) animals (blue bars). Expression was
measured in all four stages of larval development. Error bars represent standard error of measurement.
(B) RNAi of nhr-49, acs-2, or ech-1 resulted in increased Nile Red fat staining. Each image shows 3 or 4 representative worms from a population of
L4 animals grown on plates containing RNAi bacteria and Nile Red fat-staining dye.
(C) acs-2::gfp is expressed in many tissues including hypodermis (hyp), intestine (int), body wall muscle (bwm), neurons (neu), and pharynx (pha).
ACS-2::GFP localizes to subcellular structures in a pattern similar to what has been reported for mitochondrial proteins [13].
(D) Expression of acs-2::gfp was lower in nhr-49(nr2041) mutant animals.
(E) Expression of Pnhr-49::gfp promoter fusion in WT animals revealed that nhr-49 is expressed in multiple tissues, including hypodermis (hyp),
body wall muscle (bwm), pharynx (pha), and intestine (int). The animals shown here are genetically mosaic, harboring the Pnhr-49::gfp construct in
only a fraction of total cells.
(F) Ectopic expression of acs-2::gfp in nhr-49(nr2041) was sufficient to reduce Nile Red staining to WT levels.
DOI: 10.1371/journal.pbio.0030053.g003
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glucose metabolism. Thus, it is clear that nhr-49 is extensively
involved in the control of fatty acid metabolism, with a
pronounced role in the promotion of mitochondrial b-
oxidation and fatty acid desaturation.
nhr-49(nr2041) Animals are High in Fat Due to Reduced
Expression of b-Oxidation Genes
Three genes predicted to participate in mitochondrial b-
oxidation, ech-1 (C29F3.1), F09F3.9, and an acyl-CoA synthe-
tase gene (acs-2) (F28F8.2), were expressed at significantly
lower levels in nhr-49(nr2041) animals throughout develop-
ment (Figure 3A). acs-2 is predicted to encode a mitochon-
drial acyl-CoA synthetase, whereas F09F3.9 likely codes for a
carnitine palmitoyl transferase, and ech-1 appears to encode a
mitochondrial b-oxidation trifunctional enzyme. Because
mitochondrial b-oxidation facilitates the degradation of
stored fats for the production of energy, we suspected that
nhr-49(nr2041) worms might be high in fat due to the reduced
expression of these key b-oxidation enzymes. To test this
hypothesis, we used RNAi to reduce separately the expression
of acs-2, F09F3.9, and ech-1 in WT animals. Indeed, we found
that RNAi of either acs-2 or ech-1 resulted in worms with
elevated Nile Red fat staining (Figure 3B). acs-2 was previously
identified for a similar effect on fat storage [12]. We conclude
that nhr-49 promotes the expression of three b-oxidation
genes, two of which, in WT worms, reduce overall fat storage.
Thus, nhr-49(nr2041) mutant worms are likely to be high in fat
due to the impaired expression of these genes.
ACS-2 Is Expressed in Multiple Tissues and Localizes to
Mitochondria
Out of five predicted mitochondrial acs genes in C. elegans,
nhr-49 affected only the expression of acs-2, suggesting that
nhr-49 may only influence a subset of mitochondrial b-
oxidation pathways in worms. To determine if acs-2 was
expressed in a specific set of tissues, we fused the full-length
acs-2 gene and promoter to gfp (acs-2::gfp); injection of this
construct into WT worms revealed that the ACS-2::green
fluorescent protein (GFP) was widely expressed in many cell
types, including intestine, hypodermis, pharynx, body wall
muscle, and several neurons (Figure 3C). Moreover, ACS-
2::GFP expression was reduced in all of these tissues in nhr-
49(nr2041) worms, indicating that the effects of nhr-49 on acs-
2 expression were widespread (Figure 3D). Notably, the
expression pattern of acs-2 overlapped extensively with that
of an nhr-49 promoter/GFP fusion, consistent with the idea
that nhr-49 could control acs-2 through direct transcriptional
activation (Figure 3E). As predicted, ACS-2::GFP localized to
subcellular structures in patterns similar to those reported
for other mitochondrial proteins [13] (Figure 3C).
Overexpression of ACS-2::GFP Is Sufficient to Suppress the
High-Fat Phenotype of nhr-49(nr2041)
Strikingly, overexpression of the ACS-2::GFP fusion was
able to suppress the high-fat phenotype of nhr-49(nr2041)
animals (Figure 3F). These data suggest that acs-2 expression is
reduced in nhr-49(nr2041) such that it becomes a rate-limiting
factor in the consumption of fat; thus, high fat levels can be
overcome simply by increasing acs-2 expression. Overexpres-
sion of acs-2 in WT animals did not affect fat content,
however, indicating that WT levels of acs-2 expression are not
rate limiting. These data further support the conclusion that
reduced expression of acs-2 is a significant contributor to the
high-fat phenotype of the nhr-49(nr2041) mutant.
nhr-49 Modulates Fatty Acid Composition by Promoting
Expression of D9-Desaturases
In addition to stimulating genes in the mitochondrial b-
oxidation pathway, nhr-49 also promoted the expression of
three C. elegans fatty acid desaturases (see Figure 2). fat-5
(W06D12.3) and fat-7 (F10D2.9) expression was dramatically
lowered in nhr-49(nr2041) worms (.30-fold) in all four larval
stages, whereas fat-6 (VZK8221.1) expression was marginally
reduced (approximately 2-fold) only in L3 and L4 animals
(Figure 4A).
Studies in yeast have shown that the C. elegans fat-5, fat-6,
and fat-7 genes encode D9-desaturases, which preferentially
convert saturated C16:0 and C18:0 fatty acids to monounsa-
turated C16:1 and C18:1 fatty acids [14]. fat-5 is a palmitoyl-
CoA desaturase, specifically acting on palmitic acid (C16:0),
and fat-6 and fat-7 are stearoyl-CoA desaturases (SCDs),
preferentially functioning to desaturate stearic acid (C18:0).
Mammalian SCDs have been shown to be important for
maintaining an appropriate level of fatty acid desaturation,
vital for modulating membrane fluidity and for controlling
lipid metabolism [15,16]. Furthermore, in C. elegans, SCDs are
also involved in catalyzing the first step in the synthesis of
polyunsaturated fatty acids (PUFAs) [17] (see Figure 4B inset).
Because the expression of these three C. elegans D9-
desaturases was significantly impaired by nhr-49 deletion, we
used gas chromatography/mass spectrometry (GC/MS) to
determine whether overall fatty acid desaturation and PUFA
synthesis were altered in nhr-49(nr2041) animals. The most
significant consequence of nhr-49 deletion on fatty acid
composition was a marked increase in the abundance of
stearic acid (C18:0) and a corresponding decrease in the level
of oleic acid (C18:1n9) (Figure 4B). This result is consistent
with a reduction in SCD activity.
In mammals, a primary role of SCD is to control the ratio
of fully saturated stearic acid to monounsaturated oleic acid
(C18:0/C18:1n9), and this ratio has been employed as an
indicator of the activity of the mammalian SCD1 [15,16]. In C.
elegans we found that the ratio of stearic acid to oleic acid
(C18:0/C18:1n9) was increased from 1.9 in WT animals to 4.3
in nhr-49(nr2041) (Table 1). A similar but less pronounced
alteration in the ratio of stearic acid to oleic acid was
observed when nhr-49 was knocked down in WT animals using
RNAi (Figure 4B and Table 1). This smaller influence on fatty
acid desaturation likely resulted from the fact that nhr-49
RNAi did not reduce D9-desaturase expression as dramati-
cally as nhr-49 knockout (data not shown).
C. elegans SCDs are also important for the synthesis of
PUFAs; however, we did not observe any measurable changes
in PUFA abundance in nhr-49(nr2041) animals (Figure 4B).
Therefore, despite the dramatic effect of nhr-49 on SCD
activity, nhr-49 does not appear to play an appreciable role in
overall PUFA synthesis.
To determine which of the D9-desaturases accounted for
the influence of nhr-49 deletion on fatty acid composition, we
used RNAi to individually knock down expression of fat-5 and
fat-7 (because fat-6 expression is only reduced by approx-
imately 2-fold in nhr-49[nr2041], we did not examine fat-6
RNAi animals). Although we did not observe a significant
consequence of fat-5 RNAi on fatty acid desaturation, fat-7
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RNAi altered fatty acid composition in a manner very similar
to that of nhr-49 deletion (Figure 4B and Table 1). fat-7 RNAi
animals displayed a significant increase in the abundance of
C18:0 fatty acid, as well as a decrease in the levels of C18:1n9
and C18:2n6 fatty acids. The influence of fat-7 RNAi on fatty
acid composition was stronger than that of nhr-49 deletion,
increasing the ratio of stearic to oleic acid (C18:0/C18:1n9) to
8.0. fat-7 RNAi animals also exhibited a slight lowering of
PUFA abundance. The stronger effect of fat-7 RNAi on fatty
acid composition suggests that fat-7 expression was reduced
to levels even lower than those observed in nhr-49(nr2041).
Because fat-7 shares significant homology (approximately
85% nucleotide identity) with fat-6, it was possible that fat-7
RNAi also partially interfered with fat-6 expression; however,
we found by QRT-PCR that the overall levels of fat-6 mRNA
were not noticeably reduced by fat-7 RNAi. (data not shown).
Therefore, we conclude that by strongly promoting SCD
expression, nhr-49 influences fatty acid composition in C.
elegans. Although it appears that the primary effect of nhr-49
deletion is a modulation of stearic and oleic acid levels, not
Figure 4. Deletion of nhr-49 Hinders Fatty Acid Desaturation
(A) QRT-PCR measurement of fat-5, fat-6, and fat-7 expression in WT (gray bars) and in nhr-49(nr2041) mutant worms (blue bars). Expression was
measured in all four stages of larval development. Error bars represent standard error of measurement.
(B) Relative abundance of individual fatty acid species expressed as percentage of total measured fatty acid. Fatty acids included in total fatty
acid measurement but not shown in the figure include C14:0, C15:0, and C17:D. Fatty acids were isolated and quantified by GC/MS from WT
(dark gray bars), nhr-49(nr2041) (blue bars), fat-7 RNAi animals (red bars), and nhr-49 RNAi animals (light gray bars). Error bars represent
standard error. The fatty acid desaturation/elongation pathway, along with enzymes involved in desaturation and elongation, is shown in the
inset; this pathway was adapted from previous studies [14,17].
DOI: 10.1371/journal.pbio.0030053.g004
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PUFA abundance, we cannot rule out the possibility that nhr-
49 influences PUFA synthesis in a more localized manner,
such that the changes in PUFA composition are not
detectable by our whole-worm analysis.
Interference of fat-7 Expression Reproduces Shortened
Life-Span Phenotype
Using RNAi to knock down the nhr-49-dependent genes
identified in this study, we found that interference of only fat-
7 resulted in a shortened life-span phenotype similar to that
of nhr-49(nr2041) (see Table 1). fat-7 RNAi animals displayed
many of the same characteristics of the nhr-49(nr2041)
mutant, including widespread vacuole formation and germ
line necrosis (Figure 5).
Interestingly, the effect of fat-7 RNAi on life span was even
more potent than nhr-49 deletion, reducing adult life span to
3–5 d, as opposed to the 5- to 7-d life span of nhr-49(nr2041)
(see Table 1). This is consistent with the finding that SCD
activity is more dramatically compromised in fat-7 RNAi
animals than it is in the nhr-49(nr2041) mutant. In fact, we
observed a striking correlation between fat-7 activity, as
determined by the ratio of stearic to oleic acid in our various
mutants, and life span (see Table 1). WT animals (stearic/oleic
= 1.9) lived approximately 16–18 d, nhr-49 RNAi animals
(stearic/oleic = 2.3) lived approximately 10–12 d, nhr-
49(nr2041) animals (stearic/oleic = 4.3) lived approximately
6–8 d, and fat-7 RNAi animals (stearic/oleic = 8.0) lived
approximately 3–5 d.
Because fat-7 expression is significantly compromised by
nhr-49 deletion, and because lowered fat-7 expression can lead
to shortened life span, we suggest that the reduced life-span
phenotype of nhr-49(nr2041) likely reflects, at least in part,
diminished fat-7 expression.
Stimulation of fat-7 by nhr-49 Feeds Back to Inhibit b-
Oxidation
By promoting b-oxidation gene expression, nhr-49 stim-
ulates fat consumption, and by enhancing fat-7 expression,
nhr-49 modulates fat desaturation and ensures normal
longevity. We next set out to determine whether nhr-49
regulates these two pathways independently.
Although RNAi of acs-2 or ech-1 was sufficient to cause a
high-fat phenotype, acs-2 or ech-1 interference did not
Table 1. Life Span, Fat Content, and Relative C18:0 Fatty Acid
Abundance
Strain or
RNAi Sample
Fat
Content
Life
Span
Percent of Total Fatty Acid Ratio
C18:0 C18:1n9
WT WT 16–18 d 7.0 6 .8 3.7 6 0.1 1.9
nhr-49(nr2041) High 6–8 d 11.6 6 .1.6 2.7 6 0.2 4.3
nhr-49 RNAi High 10–12 d 8.5 6 1.2 3.7 6 0.6 2.3
fat-7 RNAi Low 3–5 d 14.4 6 2.0 1.8 6 0.5 8.0
fat-5 RNAi WT WT 8.4 4.1 2.0
ech-1 RNAi High WT 7.2 4.1 1.8
acs-2 RNAi High WT 7.3 4.1 1.8
Fat content was determined by Nile Red staining. Life span indicated is the day when half of the worms in a given
population expired. Fatty acid abundance is indicated by percent of total fatty acid measured by GC/MS.
DOI: 10.1371/journal.pbio.0030053.t001
Figure 5. fat-7 Is Necessary for Normal Life Span and Inhibits b-Oxidation
(A) Nomarski images of WT worms subjected to fat-7 RNAi at days 1 and 3 of adulthood. The arrow in the day 1 image points to vacuole
formation in the intestine, and the arrow in the day 3 image points to clearing that results from collapse of the gonad. These characteristics are
nearly identical to those observed for nhr-49(nr2041) worms (see Figure 1B).
(B) QRT-PCR measurement of acs-2 and ech-1 expression in WT and nhr-49(nr2041) L4 animals grown on control RNAi bacteria (dark gray bars)
or on fat-7 RNAi bacteria (blue bars). Error bars represent standard error of measurement.
(C) RNAi knockdown of fat-7 expression in WT animals reduced Nile Red fat staining
(D) RNAi of fat-7 in nhr-49(nr2041) also decreased fat staining.
DOI: 10.1371/journal.pbio.0030053.g005
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significantly impact life span, fatty acid composition, or
desaturase gene expression, demonstrating that the effects of
nhr-49 deletion on fat-7 expression and life span were not a
downstream consequence of compromised b-oxidation or
increased fat content (see Table 1).
In contrast, RNAi of fat-7 significantly impacted fat storage
and b-oxidation. The effect was paradoxical, however, as fat-7
interference produced the opposite result of nhr-49 deletion,
causing reduced fat content and increased expression of genes in
b-oxidation, including acs-2 and ech-1 (Figure 5). As the
influence of fat-7 on the expression of b-oxidation genes is
opposite that of nhr-49, it is clear that the stimulation of b-
oxidation by nhr-49 does not result from promotion of fat-7
expression. In fact, by enhancing fat-7 expression, nhr-49
indirectly causes inhibition of the very same b-oxidation
genes that it is independently stimulating (Figure 6).
Because fat-7 targets some of the same b-oxidation genes
as nhr-49, we wondered if the effects of fat-7 on fat storage
might be dependent on nhr-49; for example, perhaps fat-7
represses ech-1 and acs-2 expression by blocking the nhr-49
mediated induction of these genes. However, we found that
both ech-1 and acs-2 were induced when fat-7 was knocked
down even further in the nhr-49(nr2041) mutant using RNAi,
indicating that fat-7 hinders the expression of ech-1 and acs-2
through a mechanism that is independent of nhr-49 (see
Figure 5B). Furthermore, RNAi of fat-7 reduced fat content
in nhr-49(nr2041) worms, demonstrating that the stimulation
of fat storage by fat-7 is also not dependent upon nhr-49 (see
Figure 5D).
Taken together, our findings demonstrate that nhr-49
controls two distinct circuits within a gene network: The
stimulation of b-oxidation gene expression is independent of
fat-7, and the promotion of fat-7 expression is independent of
nhr-49’s effects on b-oxidation. However, because fat-7 ex-
pression inhibits the same b-oxidation genes induced by nhr-
49, the regulation of fat-7 by nhr-49 connects these two circuits
into a single regulatory network, serving to limit b-oxidation
through an apparent feedback mechanism (Figure 6).
Discussion
Here we demonstrated that deletion of the C. elegans nhr-49
gene produced two global phenotypes: shortened life span
and high fat content. Using a QRT-PCR strategy, we found 13
genes involved in energy metabolism that depend upon nhr-
49 for expression. The phenotypes of nhr-49(nr2041) were
attributable to deficiencies in two different metabolic path-
ways, fatty acid b-oxidation and fatty acid desaturation. The
high-fat phenotype is explained by lowered expression of b-
oxidation enzymes, and the shortened life-span phenotype
results from reduced expression of the fat-7 SCD. Interest-
ingly, these pathways are linked by an apparent feedback
mechanism, as fat-7 also serves to inhibit the expression of
fatty acid b-oxidation genes (Figure 6).
These results represent the first detailed characterization
of a divergent HNF4-like receptor in C. elegans and provide
the first description of an NHR-controlled fat-regulatory
network in invertebrates. Due to their evolutionary relation-
ship to nhr-49, it seems conceivable that many of the C. elegans
HNF4-like NHRs might participate in the regulation of fat
metabolism. However, we have found that several other worm
HNF4-like receptors, including those previously implicated
for affecting overall fat storage [12], do not significantly
impact the expression of fatty acid metabolism genes (M. R.
Van Gilst and K. R. Yamamoto, unpublished data). Thus, the
regulation of fat metabolism does not appear to be a general
mechanism common to all of the divergent NHRs; whether or
not nhr-49 is unique in its control of C. elegans fat metabolism
remains to be determined.
The mechanism by which nhr-49 influences fat storage is
likely to be through modulation of b-oxidation gene
expression (Figure 6). Overexpression of acs-2 alone was
sufficient to suppress the high-fat phenotype of nhr-
49(nr2041), indicating that acs-2 expression is rate-limiting
in nhr-49 deletion mutants, thus leading to reduced fat
breakdown and excessive fat accumulation. Acyl-CoA synthe-
tases activate fatty acids for many different metabolic
pathways; in particular, mitochondrial acyl-CoA synthetases
are likely to activate fatty acids for transport into the
mitochondrial matrix, where the fatty acids are then subject
to b-oxidation [18,19]. Notably, mitochondrial acyl-CoA
synthetases are commonly regulatory targets for factors that
control fat consumption [18]. We propose that by stimulating
acs-2 expression, nhr-49 likely acts by increasing the flow of
fatty acids into the mitochondria for b-oxidation (Figure 6).
Out of 11 acs genes in C. elegans, five of which are predicted
to be mitochondrial, nhr-49 specifically affected the expres-
sion of only acs-2, suggesting that nhr-49 may be promoting
transport of a specific subset of fatty acids into mitochondria.
These subsets may differ by fatty acid chain length or tissue
distribution. As both acs-2 and nhr-49 are expressed in
numerous C. elegans tissues, regulation of fat consumption
by nhr-49 may occur throughout the animal.
Although acs-2 is related (with approximately 25% identity)
to multiple mammalian acyl-CoA synthetases, mammals
contain a particular homolog with approximately 41%
Figure 6. Model for nhr-49 Regulation of Fat Storage and Composition
By stimulating expression of genes predicted to be involved in fatty
acid b-oxidation, nhr-49 promotes fat consumption; likely by
facilitating the flow of fatty acids (FA) into the mitochondrial matrix.
Through an independent pathway, nhr-49 modulates fatty acid
desaturation by enhancing the expression of the fat-7 SCD. Stim-
ulation of fat-7 is necessary for normal adult life span. Finally, fat-7 also
feeds back to partially inhibit expression of b-oxidation genes.
DOI: 10.1371/journal.pbio.0030053.g006
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identity to the C. elegans ACS-2 protein; this mammalian ACS
protein is yet to be characterized. It will be interesting to
determine whether the mammalian counterpart of acs-2 also
serves as an important focal point for gene networks that
regulate fat utilization in mammals.
Interestingly, we also found that nhr-49 stimulates expres-
sion of a carnitine palmitoyl transferase (F09F3.9). Carnitine
palmitoyl transferases execute the step immediately down-
stream of acyl-CoA synthetase in mitochondrial b-oxidation,
directly shuttling activated acyl-CoAs into the mitochondrial
matrix. Thus, nhr-49 appears to target multiple enzymes
involved in transporting fatty acids across the mitochondrial
membrane for b-oxidation (Figure 6). RNAi of F09F3.9 did
not detectably alter overall fat content, however, suggesting
that interference of F09F3.9 expression alone is not sufficient
to affect overall fat consumption under the conditions
surveyed in our study.
In contrast, we found that RNAi of ech-1, another b-
oxidation gene targeted by nhr-49, was sufficient to increase
overall fat content; thus it is likely that the reduced
expression of ech-1 also contributes, in some fashion, to the
high-fat phenotype of nhr-49(nr2041). Thus, we have demon-
strated that nhr-49 strongly promotes the expression of three
separate enzymes predicted to participate in mitochondrial
b-oxidation. Consequently, we suggest that nhr-49 plays a
prominent role in promoting the breakdown of fatty acids in
mitochondria, and that, through control of b-oxidation, nhr-
49 influences overall fat storage.
In addition to its effect on b-oxidation, we found that nhr-
49 helps to maintain the balance of saturated and mono-
unsaturated fatty acids. By stimulating the expression of three
fatty acid D9-desaturase genes, nhr-49 facilitates the con-
version of saturated fatty acids to monounsaturated fatty
acids, and consequently, nhr-49(nr2041) mutant animals are
high in saturated fat and lower in monounsaturated fat. In C.
elegans, the FAT-6 and FAT-7 SCDs may also be involved in
the synthesis of PUFAs [17]. However, a dramatic reduction in
fat-7 expression, either by nhr-49(nr2041) deletion or by fat-7
RNAi, did not significantly affect PUFA synthesis. This result
suggests that a normal level of FAT-7 expression is not
necessary for PUFA synthesis, likely because FAT-6 is the
principle enzyme in this pathway, or because FAT-6 is
capable of substituting for reduced FAT-7 activity. In either
event, we propose that the primary effect of nhr-49 on fatty
acid composition is a modulation of the ratio of C18:0 to
C18:1n9 fatty acid (Figure 6). However, we cannot rule out the
possibility that nhr-49 and fat-7 also affect PUFA synthesis in a
more localized manner, for example, specific cell types, such
that changes in PUFA abundance are not detected in our
whole-worm analysis.
Our results also indicate that the short life-span phenotype
of nhr-49(nr2041) is due, at least in part, to reduced
expression of fat-7. The strong correlation between the
increase in C18:0 saturated fatty acid and the shortening of
life span is compelling. Several reports in mammals have
described changes in fatty acid composition during aging,
and it has been argued that an alteration of fatty acid
saturation ratios in mitochondrial membranes may affect the
rate of aging [20]. Additionally, imbalance of fatty acid
saturation has also been linked to numerous pathological
conditions [15,16]. Although SCDs have not yet been linked to
life span in mammals, studies in C. elegans have identified fat-7
as one of the targets of the mechanisms that extend longevity
through the insulin pathway [21]. Thus, it will be interesting
to determine if the shortened life-span phenotype of nhr-
49(nr2041) and fat-7 RNAi animals results from an improper
ratio of saturated and monounsaturated fats, and if the
mechanistic cause of the reduced life span is related to
accelerated aging or to another pathology.
Although it is clear that nhr-49 independently promotes the
expression of genes in fatty acid b-oxidation and desaturation,
we found that downstream components of these pathways do
indeed communicate with each other. By inhibiting the
expression of genes involved in b-oxidation, including the
nhr-49-dependent genes acs-2 and ech-1, fat-7 works against the
actions of nhr-49, acting to hinder fat consumption (Figure 6).
Thus, our results reveal an elegant feedback mechanism: nhr-
49 induces the expression of b-oxidation enzymes—thus
promoting fat consumption—yet by independently stimulat-
ing fat-7 expression, nhr-49 tempers the expression of the very
same b-oxidation genes (Figure 6). Thus, we suggest that nhr-49
serves as a key regulator of fat usage, governing pathways that
consume fat for energy and partition fat for storage,
potentially shifting the balance in response to changing
energy needs. Indeed, we have found that in response to
starvation, nhr-49 selectively modulates the expression of
these two pathways in order to increase fat consumption (M.
R. Van Gilst and K. R. Yamamoto, unpublished data).
As the predominant function of fat-7 is to convert C18:0 to
C18:1n9 fatty acid, it is tempting to speculate that one of
these two fatty acid species serves as a signal to modulate the
feedback effect of fat-7 on fatty acid b-oxidation (Figure 6). In
this scenario, C18:0 could be serving as an activator of b-
oxidation gene expression, C18:1n9 could be functioning as a
repressor, or both (Figure 6). Although it seems reasonable to
propose that an NHR would communicate this fatty acid
signal, we found that the effects of fat-7 on fatty acid b-
oxidation were not dependent on nhr-49; hence, one of the
other 283 C. elegans NHRs may mediate this effect.
Despite its strong sequence similarity with the mammalian
HNF4 receptors, the overall biological effects of nhr-49 on
metabolism, fat storage, and life span are remarkably similar
to those of the mammalian PPARs. Perhaps most striking is
the finding that nhr-49 and the PPARs, particularly PPARa
and PPARd, positively influence similar genes in multiple
metabolic processes, including fatty acid b-oxidation, fatty
acid desaturation, and fatty acid binding/transport [22,23].
Moreover, knockout of PPARa or PPARd can lead to high-fat
phenotypes [23,24], demonstrating that the physiological
effects of these receptors on fat storage are similar to those
of nhr-49.
The regulation of SCDs by nhr-49 also parallels the
regulation of the SCD1 gene by PPARa. In mammals, the
D9-desaturase SCD1 is a lipogenic enzyme that is controlled
by several key regulators of fat storage, including PPARa,
leptin, and sterol response element-binding protein
[15,25,26]. When SCD1 expression is left unchecked, as occurs
in leptin knockout mice, severe obesity can result. Similar to
what we found for the C. elegans fat-7 gene, mammalian SCD1
affects fat storage by inhibiting b-oxidation [27]. Thus,
because PPARa also promotes fat consumption by stimulat-
ing b-oxidation gene expression[28], it is clear that PPARa is
independently regulating pathways that promote fat con-
sumption and stimulate fat storage. In fact, a similar feedback
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mechanism to what we have described here for nhr-49 has
been proposed for PPARa and SCD1 [27,29]. Taken together,
these results demonstrate that the multicircuited regulatory
networks governing fat usage appear well conserved between
C. elegans nhr-49 and the mammalian PPARa.
Although we have not yet determined whether or not the
nhr-49-dependent genes identified in this study are direct
transcriptional targets, each is homologous to known tran-
scriptional targets of the PPARs [22,23]. Because NHR-49 and
the PPARs are clearly regulating similar physiological
processes and gene networks, we believe that they are likely
to be using similar molecular mechanisms, including direct
transcriptional regulation. However, it is possible that nhr-49
controls fatty acid b-oxidation and desaturation through an
indirect mechanism, functioning upstream of the transcrip-
tion factors that directly act on the nhr-49-dependent genes
identified in this study. The latter possibility would also be
intriguing, as it would demonstrate NHR involvement in fat
regulation at a point upstream of a PPAR-like factor.
As the physiological functions and regulatory targets of
nhr-49 are highly similar to those of the mammalian PPARs, it
seems reasonable to speculate that, like the PPARs, NHR-49
may be regulated by fatty acid ligands. By binding directly to
ingested lipids and/or their metabolic products, NHR-49
could serve both as a sensor of intracellular fatty acid levels
and an effector, responding to changes in fatty acid
composition through modulation of fatty acid b-oxidation
and desaturation. Interestingly, the mammalian HNF4 re-
ceptors, whose LBDs share 33% identity with the NHR-49
LBD, can bind to several saturated and monounsaturated
fatty acids, including stearic and oleic acid [30,31]; the
mammalian PPARs also bind to many types of fatty acids,
although they interact preferentially with PUFAs [22]. It will
be interesting to determine if mammalian HNF4 receptors
harbor an undiscovered capacity to regulate fat metabolism
in mammals, or if PPARs have adopted their regulatory
functions by evolving from an ancestral HNF4 gene that had
properties similar to nhr-49 and the modern PPARs. Alter-
natively, the PPARs and nhr-49 may have acquired their
activities through convergent evolution.
Precise regulation of fatty acid b-oxidation and desatura-
tion is crucial for physiological homeostasis; imbalance in
thesemetabolic pathways in humans can lead to disorders such
as diabetes, obesity, atherosclerosis, and accelerated aging.
However, although NHRs are important targets for drugs that
moderate these metabolic disorders, the NHR-mediated
regulatory networks that govern fat usage are notably complex
and poorly understood. We showed here that many features of
C. elegans nhr-49 regulation of fat metabolism are closely
analogous to those of the mammalian PPARs, key targets for
the treatment of metabolic disease. Moreover, our C. elegans
studies revealed that nhr-49, like PPARa, oversees a branch
point for two separate circuits within a network that controls
fatty acid consumption and composition.
The extent of the functional homology between nhr-49 and
PPARa remains to be determined, that is, whether or not nhr-
49 also functions by binding to fatty acid ligands and directly
regulating gene transcription. Nevertheless, our finding that
nhr-49 is a key regulator of fat metabolism in C. elegans
represents a considerable advance in our understanding of
NHR control of fat storage and composition in invertebrates.
Consequently, we suggest that these and future studies in C.
elegans will continue to enhance our understanding of the
complex roles of NHRs and their ligands on gene networks
governing fat physiology.
Materials and Methods
RNAi constructs. All of the RNAi constructs used in the NHR
screen were created by cloning full-length NHR cDNAs into the
vector L4440 (Andy Fire, Stanford University). The fat-7 RNAi vector
was a gift from Jennifer Watts (Washington State University). All of
the other RNAi constructs were obtained from the Ahringer RNAi
library [32].
Life span assays. Approximately 30–40 starved L1 worms were
transferred to RNAi bacteria (HT115 transformed with RNAi clone)
and life-span assays were carried out at 23 8C as described previously
[33]. nhr-49(nr2041) and WT life-span assays were carried out at 23 8C
on OP50 bacteria.
Nile Red assays. Nile Red fat-staining assays were carried out as
described previously [12].
Selection of fatty acid and glucose metabolism genes. Most of the
fatty acid and glucose metabolism candidate genes examined in this
study were initially identified using the KEGG pathway database
(http://www.genome.ad.jp/kegg/pathway.html). Other genes were iden-
tified using BLAST searches designed to find C. elegans open reading
frames that were highly related to known mammalian glucose and fat
metabolism enzymes, or to plant glyoxylate cycle genes.
For prediction of b-oxidation enzyme subcellular localization, we
used the following online prediction tools. TargetP server version
1.01 (http://www.cbs.dtu.dk/services/TargetP/) [34] and PSORT (http://
psort.nibb.ac.jp/form.html).
Preparation of nematode total RNA. Both C. elegans N2-Bristol
(WT) and nhr-49(nr2041) were grown at 23 8C on high-growth plates
seeded with OP50 bacteria. Gravid adults from 30 10-cm plates were
bleached, and embryos were dispersed onto 15-cm nematode growth
media (NGM)-lite plates seeded with OP50. The worms were
distributed as follows: for L1 harvest, 80,000 embryos/plate; for L2
harvest, 40,000 embryos/plate; for L3 harvest, 20,000 embryos/plate;
and for L4 harvest, 10,000 embryos/plate. The remaining embryos
were saved for embryonic RNA preparation. Worms were harvested
at the appropriate stage, washed twice with M9, and frozen in liquid
nitrogen. For RNAi experiments, 10,000 embryos were placed onto
NGM-lite plates containing 8 mM IPTG and 100 lg/ml carbenicillin
seeded with control bacteria (HT115 transformed with empty L4440
vector) or nhr-49 RNAi bacteria (HT115 transformed with L4440-nhr-
49). Worms were harvested at the L4 stage of development, washed
twice with M9, and frozen in liquid nitrogen. For RNA preparation,
worms were thawed at 65 8C for 10 min, and RNA was isolated using
the Tri-Reagent Kit (Molecular Research Center, Cincinnati, Ohio,
United States). Isolated total RNA was subjected to DNAase treatment
and further purification using RNAeasy (Qiagen, Valencia, California,
United States).
QRT-PCR. cDNA was prepared from 5 lg of total RNA in a 100-ll
reaction using the Protoscript cDNA preparation kit (New England
Biolabs, Beverly, Massachusetts, United States). Primer pairs (primer
sequences available upon request) were diluted into 96-well cell
culture plates at a concentration of 3 lM. Next, 30-ll PCR reactions
were prepared in 96-well plates. Each PCR reaction was carried out
with TaqDNA Polymerase (Invitrogen, Carlsbad, California, United
States) and consisted of the following reaction mixture: 0.3 lM
primers, 1/500th of the cDNA reaction (corresponds to cDNA derived
from 10 ng of total RNA), 125 lM dNTPs, 1.5 mM MgCl2, and 1X
reaction buffer (20 mM Tris pH 8.4, 50 mM KCl). 0.15 ll (0.75 units) of
TaqDNA Polymerase was used for each reaction. Formation of
double-stranded DNA product was monitored using SYBR-Green
(Molecular Probes, Eugene, Oregon, United States). All QRT-PCR
reactions were carried out and analyzed on a DNA Engine-Opticon 2
(MJ Research, Waltham, Massachusetts, United States). Data were
collected using RNA from at least three independent C. elegans
growths. To determine the relationship between mRNA abundance
and PCR cycle number, all primer sets were calibrated using serial
dilutions of cDNA preparations. Primer sets were also calibrated by
performing QRT-PCR reactions on serial dilutions of C. elegans
genomic DNA. Relative abundance is reported as the mRNA
abundance of each gene relative to the mRNA abundance of several
control genes, which are expressed at constant levels throughout
development.
GC/MS. Fatty acids were isolated from 10,000 L4 animals grown on
a single 15-cm NGM-Lite plate. For WT and nhr-49(nr2041) experi-
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ments, worms were grown at 23 8C on a lawn of OP50. For RNAi,
10,000 embryos were placed on control bacteria, or on fat-5, fat-7, ech-
1, acs-2, or nhr-49 RNAi bacteria. Fatty acid extract was prepared as
described previously [17]. GC/MS spectra were collected on an HP
6890 gas chromatograph outfitted with a J&W DB-XLB column. The
mass spectrometer was an HP MSD 5973 (Agilent, Palo Alto,
California, United States) and data were analyzed using Chemstation
version A.03.00 software (Agilent). Peaks were assigned using fatty
acid standards.
GFP reporter analysis and ectopic expression of ACS-2::GFP. To
make the Pnhr-49GFP plasmid, a genomic fragment including 3.5 kb of
the nhr-49 upstream sequence and 88 bp of the first exon of nhr-49
was ligated into the L3691 GFP expression vector (a gift of A. Fire).
Germ-line transformation was performed following standard proce-
dures [35]. Pnhr-49GFP was injected at the following concentrations: 1
ng/ll, 5 ng/ll and 20 ng/ll along with the co-injection marker pRF4
rol-6(su1006) injected at 60 ng/ll. At all three Pnhr-49GFP concen-
trations, we were unable to obtain stably transmitting lines. Animals
used for GFP imaging were derived from the F1 generation and were
mosaic, hosting the Pnhr-49GFP transgene in only a subset of tissues.
To construct acs-2::gfp, a 4-kb genomic fragment, including the full-
length acs-2 gene plus 2 kb of upstream sequence, was cloned into the
vector L3691. Germ-line transformation was performed using 50 ng/
ll of acs:2::gfp and 50 ng/ll pRF4 rol-6(su1006). For N2/acs-2::gfp and
nhr-49(nr2041)/acs-2::gfp, over ten independent transmitting lines were
obtained and analyzed by GFP microscopy. GFP reporter expression
was observed using a Zeiss Axiovert S100 fluorescence microscope
(Carl Zeiss, Thornwood, New York, United States) under a 40X
objective.
For rescue experiments, 50–100 ng/ll of acs-2::gfp was injected into
nhr-49(nr2041) and WT animals along with 50 ng/ll of pRF4 rol-
6(su1006). Transgenic adults, selected for rolling behavior, were
placed on Nile Red plates and assayed for fat content as described
above. pRF4 rol-6(su1006) was injected into nhr-49(nr2041) in
combination with unrelated plasmids to demonstrate that the
lowered fat content was not a result of hosting a transgenic array
or caused by expression of the rol-6(su1006) marker gene.
Supporting Information
Table S1. Raw Data for QRT-PCR Screen
Data are shown as Ct, the number of cycles required for amplification
of a particular target gene from a cDNA preparation. Changes in
gene expression in the nhr-49(nr2041) mutant were measured as DCt.
DCt are obtained by subtracting nhr-49(Ct) from N2(Ct) and adjusting
for RNA concentration differences with a correction factor (CF). The
CF was determined by aligning the data to a set of standard genes.
Thus the equation for DCt is as follows:
DCt = nhr-49(Ct)  N2 (Ct) þ CF. (1)
Genes were designated as nhr-49 dependent if the Ct was .1.0 in
multiple developmental stages (and was greater than the standard
error). nhr-49 targets are marked with an X. The QRT-PCR results of
the major nhr-49 targets, acs-2, ech-1, fat-5, and fat-7, were confirmed
with a second primer pair.
Found at DOI: 10.1371/journal.pbio.0030053.st001 (100 KB XLS).
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